Nikhilesh Kakati
Conference Series LLC Ltd hosted the “Cancer Science”, during May 25-26, 2020 at Rome, Italy with the theme- “Strengthening the future to fight against cancer”, which was a great success. Eminent keynote speakers from various reputed institutions and organizations addressed the gathering with their resplendent presence. We extend our grateful thanks to all the momentous speakers, conference attendees who contributed towards the successful run of the conference.
Cancer Science 2020 explored the new ideas and concepts on prevention, diagnosis, and treatment of the Organ-related Cancers and its innovative techniques with an interdisciplinary stage to experts, professionals and teachers to display and discuss about the latest developments in the fields of clinical oncology and molecular diagnostic techniques. Cancer Science Organizing Committee extends its gratitude and congratulates the Honorable Moderators of the conference.
Conference Series LLC Ltd extends its warm gratitude to all the Honorable Guests and Keynote Speakers of “Cancer Science 2020”.
Conference Series LLC Ltd is privileged to felicitate Cancer Science 2020 Organizing Committee, Keynote Speakers, Chairs & Co-Chairs and the Moderators of the conference whose support and efforts made the conference to move on the path of success. Conference Series LLC LTD thanks every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Cancer Science and Therapy.
Conference Series LLC Ltd is glad to announce its “41th Euro Congress on Cancer Science & Therapy cordially welcome all the eminent researchers, Presidents, CEO’s, Academicians, Oncologists, pathologists, Cancer & Oncology Societies Professionals, Bio-Medical Company professionals, Pharmacists, Business Entrepreneurs, medical devices companies, researchers in Cancer Science and Therapy delegates to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future research in the field of cancer science with 30% abatement on the early bird prices.
இந்தக் கட்டுரையைப் பகிரவும்